Observations placeholder
Trimeprazine Tartrate
Identifier
020239
Type of Spiritual Experience
Background
A description of the experience
Alimemazine (INN), also known as trimeprazine (USAN and former BAN); brand names Nedeltran, Panectyl, Repeltin, Therafene, Theraligene, Theralen, Theralene, Vallergan, Vanectyl, and Temaril), commonly provided as a tartrate salt, is a phenothiazine derivative that is used as an antipruritic (it prevents itching from causes such as eczema or poison ivy, by acting as an antihistamine). It also acts as a sedative, hypnotic, and antiemetic for prevention of motion sickness. Although it is structurally related to drugs such as chlorpromazine, it is not used as an antipsychotic. In the Russian Federation, it is marketed under the brand name Teraligen for the treatment of anxiety disorders (including GAD), organic mood disorders, sleep disturbances, personality disorders accompanied by asthenia and depression, somatoform autonomic dysfunction and various neuroses.
Alimemazine is not approved for use in humans in the United States.
On Feb, 13, 2016: 328 people reported to have side effects when taking Trimeprazine tartrate. Among them, 3 people (0.91%) have Hallucination.
On Feb, 13, 2016: 328 people reported to have side effects when taking Trimeprazine tartrate. Among them, 16 people (4.88%) have Death.
Time on Trimeprazine tartrate when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 33.33% | 66.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Trimeprazine tartrate :
| Female | Male | |
| Death | 17.65% | 82.35% |
Age of people who have Death when taking Trimeprazine tartrate :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.00% | 0.00% | 29.41% | 5.88% | 17.65% | 47.06% | 0.00% |